Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals

R. J. Brüggemann, D. J.A.R. Moes, K. P. van Rhee, N. E. van 't Veer, B. C.P. Koch, M. van Rossum, A. Vermeulen Windsant - van den Tweel, M. H.E. Reijers, R. R.J. van Kimmenade, J. C. Rahamat-Langedoen, T. C.D. Rettig, R. van Raalte, J. van Paassen, F. N. Polderman, P. D. van der Linden, T. Frenzel, Q. de Mast, D. M. Burger, J. Schouten, F. L. van de VeerdonkP. Pickkers, R. ter Heine*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number106293
JournalInternational Journal of Antimicrobial Agents
Volume57
Issue number3
Early online date27 Jan 2021
DOIs
Publication statusPublished - Mar 2021

Cite this